Yazhuo Zhang Selected Research

Growth Hormone-Secreting Pituitary Adenoma

1/2021	CDKN2A (p16INK4A) affects the anti‑tumor effect of CDK inhibitor in somatotroph adenomas.
1/2021	In Vivo Characterization of Cortical and White Matter Microstructural Pathology in Growth Hormone-Secreting Pituitary Adenoma.
10/2019	Impact of SLC20A1 on the Wnt/β‑catenin signaling pathway in somatotroph adenomas.
1/2019	Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas.
7/2017	EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.
5/2016	Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yazhuo Zhang Research Topics

Disease

62	Neoplasms (Cancer) 07/2022 - 12/2004
43	Pituitary Neoplasms (Pituitary Adenoma) 05/2022 - 01/2009
16	Prolactinoma (Prolactinomas) 01/2022 - 01/2009
12	Chordoma 12/2021 - 02/2017
12	Adenoma (Adenomas) 04/2021 - 02/2012
12	Carcinogenesis 01/2020 - 12/2004
9	Glioma (Gliomas) 01/2021 - 02/2002
6	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2015
6	Growth Hormone-Secreting Pituitary Adenoma 01/2021 - 05/2016
4	Cysts 10/2021 - 03/2013
3	Hydrocephalus (Hydrocephaly) 10/2021 - 07/2017
3	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2012
2	ACTH-Secreting Pituitary Adenoma 01/2022 - 01/2018
2	Inflammation (Inflammations) 05/2021 - 01/2020
2	Acromegaly 01/2021 - 01/2020
2	Plasmacytoma 11/2019 - 02/2019
2	Wounds and Injuries (Trauma) 01/2019 - 01/2015
2	Brain Injuries (Brain Injury) 12/2016 - 01/2015
2	Brain Edema (Cerebral Edema) 12/2016 - 01/2015
2	Arachnoid Cysts (Intracranial Arachnoid Cysts) 04/2016 - 06/2013
2	Body Weight (Weight, Body) 01/2015 - 01/2010
1	Craniopharyngioma (Craniopharyngiomas) 08/2022
1	Rheumatoid Arthritis 01/2022
1	Experimental Arthritis 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2021
1	Ganglion Cysts (Ganglion) 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2021 - 01/2012
14	Biomarkers (Surrogate Marker)IBA 06/2021 - 09/2014
13	ProlactinIBA 12/2020 - 01/2009
13	Growth Hormone (Somatotropin)IBA 01/2020 - 09/2010
10	Biological ProductsIBA 07/2022 - 04/2011
10	Messenger RNA (mRNA)IBA 01/2020 - 07/2008
8	Fulvestrant (Faslodex)FDA Link 01/2017 - 01/2009
7	Estrogens (Estrogen)FDA Link 01/2017 - 01/2009
6	CateninsIBA 11/2021 - 02/2014
6	Hormones (Hormone)IBA 04/2021 - 07/2012
5	LigandsIBA 05/2022 - 03/2013
5	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2017
5	Long Noncoding RNAIBA 01/2021 - 08/2017
4	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2015
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2016
4	Epidermal Growth Factor (EGF)IBA 01/2020 - 07/2017
4	Pharmaceutical PreparationsIBA 01/2016 - 07/2011
4	Estrogen Receptor AntagonistsIBA 06/2014 - 04/2011
4	Estrogen ReceptorsIBA 02/2014 - 12/2011
3	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 01/2018
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 04/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 12/2011
3	Cyclin B1IBA 10/2019 - 09/2017
3	extracellular matrix receptorIBA 01/2019 - 09/2010
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2018 - 02/2017
3	Bromocriptine (Parlodel)FDA LinkGeneric 04/2015 - 05/2013
3	Dopamine Agonists (Dopamine Agonist)IBA 04/2015 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2012
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021 - 01/2020
2	Sincalide FDA Link 01/2021 - 01/2017
2	Small Interfering RNA (siRNA)IBA 01/2021 - 10/2013
2	Cadherins (E-Cadherin)IBA 01/2021 - 10/2019
2	Aspartic Acid (Aspartate)FDA Link 01/2020 - 12/2016
2	Taurine FDA Link 01/2020 - 01/2015
2	Amino Acids FDA Link 01/2019 - 01/2015
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2018
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 09/2017 - 04/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 12/2016 - 01/2015
2	Cyclin-Dependent Kinase 5IBA 08/2016 - 01/2014
2	WD repeat containing planar cell polarity effectorIBA 07/2016 - 06/2015
2	amsonic acid (DAS)IBA 04/2015 - 02/2015
1	16S Ribosomal RNAIBA 05/2022
1	GlucansIBA 04/2022
1	RNA Splicing FactorsIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Ubiquitinated ProteinsIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Histone DemethylasesIBA 01/2022
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022
1	GSK-J4IBA 01/2022
1	ChromatinIBA 12/2021
1	Chloroquine (Aralen)FDA LinkGeneric 12/2021
1	SMARCB1 ProteinIBA 12/2021
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	NucleotidesIBA 05/2021
1	DNA (Deoxyribonucleic Acid)IBA 05/2021
1	ProdrugsIBA 05/2021
1	LuciferasesIBA 05/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	MethyltransferasesIBA 01/2021
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2021

Therapy/Procedure

14	Therapeutics 01/2021 - 01/2009
5	Radiotherapy 01/2021 - 01/2016
4	Drug Therapy (Chemotherapy) 01/2021 - 10/2013
4	Ventriculostomy 01/2018 - 06/2013
3	Immunotherapy 06/2021 - 01/2012
3	Craniotomy 04/2016 - 06/2013
2	Endoscopes 10/2021 - 01/2018
2	Adjuvant Radiotherapy 09/2020 - 02/2019
2	Length of Stay 01/2018 - 01/2016
2	Ventriculoperitoneal Shunt 07/2017 - 06/2006
1	Contraindications 08/2022
1	Fecal Microbiota Transplantation 05/2022